The latest financial statement is for the year ending 2026-01-25.
| Cash Flow | 2026-01-25 | 2025-01-26 | 2024-01-28 | 2023-01-29 |
|---|---|---|---|---|
| Intangible impairment | - | - | 131,385 | - |
| Impairment of goodwill | - | - | 755,621 | - |
| Net loss | -40,376 | - | -1,092,029 | 61,372 |
| Depreciation and amortization | 40,807 | - | 77,968 | 32,151 |
| Amortization of right-of-use assets | 5,522 | - | 6,484 | 4,742 |
| Investment impairments and credit loss reserves, net | - | - | 3,929 | - |
| Right-of-use asset impairment | 0 | - | 3,884 | - |
| Investment impairments and credit loss reserves, net | 10,387 | - | 3,900 | 1,156 |
| Impairment of goodwill | 84,785 | - | 755,600 | - |
| Changes in the fair value of contingent earn-out obligations | - | - | 0 | 0 |
| Intangible impairment | 1,777 | - | 131,400 | - |
| Accretion of deferred financing costs and debt discount | 4,788 | - | 7,320 | 1,421 |
| Write-off of deferred financing cost and debt discount | 2,388 | - | 4,446 | - |
| Loss on extinguishment of debt | 0 | - | - | - |
| Induced conversion expense | 21,188 | - | - | - |
| Interest rate swap termination | 1,145 | - | - | - |
| Deferred income taxes | -7,874 | - | -40,636 | 15,256 |
| Share-based compensation | 57,723 | - | 40,170 | 39,248 |
| Loss (gain) on disposition of business operations and assets | -75 | - | -8 | 18,260 |
| Equity in net (gains) losses of equity method investments | 636 | - | 45 | 249 |
| Gain from sale of investments | 0 | - | - | - |
| Amortization of inventory step-up | - | - | 3,314 | - |
| Corporate owned life insurance, net | -2,917 | - | -4,746 | -810 |
| Amortization of inventory step-up | 0 | - | 3,300 | - |
| Accounts receivable, net | -3,343 | - | -27,443 | -2,445 |
| Inventories | 30,652 | - | -57,308 | 3,752 |
| Other assets | 12,033 | - | -1,817 | -6,302 |
| Accounts payable | 22,530 | - | -44,346 | -3,697 |
| Accrued liabilities | 5,011 | - | -118,517 | 18,921 |
| Other liabilities | -5,105 | - | -5,462 | -643 |
| Premiums paid for corporate-owned life insurance | - | - | - | 5,065 |
| Net cash provided by (used in) operating activities | 181,168 | 57,987 | -93,920 | 126,711 |
| Proceeds from sale of business, net of cash disposed | - | 0 | 0 | 26,193 |
| Proceeds from sales of property, plant and equipment | 8 | 97 | 410 | 38 |
| Purchase of property, plant and equipment | 9,783 | 7,861 | 29,185 | 28,323 |
| Proceeds from sale of investments | 1,936 | 2,650 | 0 | 2,275 |
| Purchase of investments | 0 | 434 | 930 | 6,748 |
| Purchase of intangibles | 6,022 | 6,341 | 1,915 | - |
| Acquisition, net of cash acquired | 21,472 | 0 | 0 | 1,240,757 |
| Proceeds from corporate-owned life insurance | 0 | 4,802 | 8,923 | 5,065 |
| Premiums paid for corporate-owned life insurance | 3,428 | 4,800 | 0 | 5,100 |
| Net cash used in investing activities | -38,761 | -11,887 | -22,697 | -1,247,322 |
| Proceeds from revolving line of credit | 0 | 68,250 | 70,000 | 10,000 |
| Proceeds from sale of warrants | - | 0 | 0 | 42,909 |
| Payments of revolving line of credit | 0 | 283,250 | 5,000 | 33,000 |
| Proceeds from term loans | - | 0 | 0 | 895,000 |
| Payments of term loans | 181,212 | 441,413 | 272,375 | - |
| Proceeds from convertible senior notes | 402,500 | 0 | 250,000 | 319,500 |
| Payments of convertible senior notes | 280,950 | - | - | - |
| Repurchase of warrants | 217,761 | - | - | - |
| Proceeds from unwind of convertible note hedge | 242,251 | - | - | - |
| Purchase of capped calls | 31,395 | - | - | - |
| Proceeds from issuance of common stock, net of issuance costs | 0 | 640,675 | - | - |
| Proceeds from interest rate swap termination | 295 | 4,776 | - | - |
| Deferred financing costs | 11,653 | 824 | 25,361 | 21,760 |
| Repurchase of common stock | - | 0 | 0 | 50,000 |
| Payments for employee share-based compensation payroll taxes | 27,293 | 14,025 | 6,714 | 14,190 |
| Purchase of convertible note hedge | - | 0 | 0 | 72,559 |
| Proceeds from exercise of stock options | 4,150 | 4,335 | 0 | 620 |
| Payments of earn-out | - | - | 0 | 0 |
| Distributions to noncontrolling interest | 0 | 184 | - | - |
| Net cash (used in) provided by financing activities | -101,068 | -21,660 | 10,550 | 1,076,520 |
| Effect of foreign exchange rate changes on cash and cash equivalents | 2,097 | -1,282 | -858 | - |
| Net increase (decrease) in cash and cash equivalents | 43,436 | 23,158 | -106,925 | - |
| Cash and cash equivalents at beginning of period | 151,743 | - | - | - |
| Net (decrease) increase in cash and cash equivalents | - | - | - | -44,091 |
| Cash and cash equivalents at end of period | 195,179 | - | - | - |
SEMTECH CORP (SMTC)
SEMTECH CORP (SMTC)